Search results for "genetics [Cerebellar Neoplasms]"

showing 10 items of 3028 documents

Mitochondrial dysfunction in cholestatic liver diseases

2011

et al.

medicine.medical_specialtyMitochondrial DNABiliary cirrhosisMitochondrial HepatopathyApoptosisReviewBiologyMitochondrionmedicine.disease_causeGeneral Biochemistry Genetics and Molecular BiologyLiver diseaseCholestasisInternal medicinemedicineHumansBiología y BiomedicinaCholestasisGeneral Immunology and MicrobiologyLiver Diseasesmedicine.diseaseBile acidsCell biologyMitochondriaEndocrinologyMitochondrial biogenesisOxidative stressMitochondrial functionMitochondrial dysfunctionOxidative stressFrontiers in Bioscience (Elite edition) 4: 2233-2252 (2012)
researchProduct

2018

Beyond the classical paradigm that presents the Anticipatory Postural Adjustments (APAs) as a manner to create forces that counteract disturbances arising from the moving segment during a pointing task, there is a controversial discussion about the role APAs to facilitate the movement and perform a task accurately. In addition, arm kinematics features are classically used to infer the content of motor planning for the execution and the control of arm movements. The present study aimed to disentangle the conflicting role of APAs during an arm-pointing task in which the subjects reach a central diode that suddenly turns on, while their postural stability was manipulated. Three postures were a…

medicine.medical_specialtyMotor planningGeneral Neuroscience030229 sport sciencesGeneral MedicineKinematicsSittingGeneral Biochemistry Genetics and Molecular BiologyDeceleration time03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationPostural stabilitymedicineMotor planGeneral Agricultural and Biological SciencesPsychologypsychological phenomena and processes030217 neurology & neurosurgeryPeerJ
researchProduct

Effects of a Rehabilitation Program on Perceived Environmental Barriers in Older Patients Recovering from Hip Fracture: A Randomized Controlled Trial

2013

Objectives. To study effects of a one-year multicomponent intervention on perceived environmental barriers in hip fracture patients.Design. Randomized controlled trial of a 12-month home-based rehabilitation aiming to improve mobility and function (ISRCTN53680197); secondary analyses.Subjects. Community-dwelling hip fracture patients on average 70 days after trauma (n=81).Methods. Assessments at baseline, 3, 6, and 12 months later included perceived entrance-related barriers (e.g., indoor/outdoor stairs, lighting, floor surfaces, and storage for mobility devices) and perceived barriers in the outdoor environment (poor street condition, hilly terrain, long-distances, and lack of resting plac…

medicine.medical_specialtyMultivariate analysisTime FactorsympäristöArticle Subjectmedicine.medical_treatmentPsychological interventionlcsh:MedicineEnvironmentGeneral Biochemistry Genetics and Molecular Biologylaw.inventionfemoral fracturePhysical medicine and rehabilitationStairsOlder patientsRandomized controlled triallawmedicineta319HumansAgedAged 80 and overHip fractureRehabilitationGeneral Immunology and Microbiologybusiness.industryHip Fractureskotikuntoutuslcsh:RagingCase-control studyGeneral Medicinemedicine.diseaseikääntyminensaavutettavuusCase-Control StudiesMultivariate AnalysisPhysical therapyClinical Studykuntoutuslonkkamurtumaesteettömyys ja saavutettavuusbusinessBioMed Research International
researchProduct

2015

Several point mutations have been identified in human aquaporins, but their effects on the function of the respective aquaporins are mostly enigmatic. We analyzed the impact of the aquaporin 2 mutation V71M, which causes nephrogenic diabetes insipidus in humans, on aquaporin structure and activity, using the bacterial aquaglyceroporin GlpF as a model. Importantly, the sequence and structure around the V71M mutation is highly conserved between aquaporin 2 and GlpF. The V71M mutation neither impairs substrate flux nor oligomerization of the aquaglyceroporin. Therefore, the human aquaporin 2 mutant V71M is most likely active, but cellular trafficking is probably impaired.

medicine.medical_specialtyMutationurogenital systemPoint mutationMutantAquaporinBiologymedicine.disease_causeNephrogenic diabetes insipidusmedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyCell biologyEndocrinologyAquaporin 2Internal medicineArginine vasopressin receptor 2medicineProtein oligomerizationFEBS Open Bio
researchProduct

3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography

2021

eLife 10, e71359 (2021). doi:10.7554/eLife.71359

medicine.medical_specialtyMyocarditisViral MyocarditisQH301-705.5Science030204 cardiovascular system & hematologyStructure tensorGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineArtificial IntelligencemedicineHumansBiology (General)Intussusceptive angiogenesis030304 developmental biologyx-ray tomography0303 health sciencesGeneral Immunology and MicrobiologySARS-CoV-2business.industryGeneral NeuroscienceMyocardiumQRX-rayHeart600General Medicinemedicine.disease3. Good healthCross section (geometry)MyocarditisEpidemiology and Global Healthcardiac tissueMedicineHistopathologyTomographyTomography X-Ray ComputedCovid-19businessddc:600SynchrotronsResearch ArticleHumanBiomedical engineering
researchProduct

Monitoring and use of antimycotic (micafungin) for systemic use provided by the pharmacy of Marsala Hospital, Italy

2016

Micafungin is an antimycotic drug and represents an important addition to the available therapies for the treatment of systemic fungal infections. Micafungin is used: in the treatment of invasive candidiasis, oesophageal and prophylaxis of <em>Candida</em> infections. It inhibits, in a non-competitive way, the synthesis of 1,3-β-D-glucan, a component of fungal cell wall and is rapidly distributed into the tissues. It has a high-rate respectful bond with plasma protein, which is independent from the concentration of the drug. It is metabolized through the liver, being not subject to intense metabolic transformations until the excretion. There is no evidence of systemic accumulati…

medicine.medical_specialtyNauseaAnemiaPharmacyPlant SciencePharmacyGeneral Biochemistry Genetics and Molecular BiologyHypomagnesemiaExcretion03 medical and health sciencesHospital Pharmacy0302 clinical medicine030225 pediatricsInternal medicineIntensive caremedicineAntimycotic030212 general & internal medicineSicilylcsh:QH301-705.5Antimycotic; Micafungin; Hospital Pharmacybusiness.industryBiochemistry (medical)Micafunginmedicine.diseaseHypokalemiaSurgerylcsh:Biology (General)MicafunginSettore BIO/14 - Farmacologiamedicine.symptombusinessmedicine.drug
researchProduct

Correlates of hormone replacement therapy use in Italian women, 1992-1996

1999

we analyzed the determinants of hormonal replacement therapy (HRT) use in Italy for the period 1992-1996, using data from a framework of case-control studies of colon and rectal neoplasm.a total of 1574 women aged 45-74 years were considered. This group comprised women with acute, non neoplastic, non-hormone-related diseases admitted to a network of hospitals in six areas of Italy.a total of 146 women (8.5%) reported ever HRT use. The multivariate odds ratio (OR) of ever use was 1.6 (95% CI 1.0-2.6) for women with 12 years of education or more, compared with those with7 years. The frequency of use of HRT tended to decrease with increasing parity: the OR was 0.6 for women with four or more c…

medicine.medical_specialtyNon neoplasticmenopauseGeneral Biochemistry Genetics and Molecular BiologyInternal medicineRectal NeoplasmmedicineHumansSocioeconomic statusAgedClimactericGynecologybusiness.industryEstrogen Replacement TherapyHormonal replacement therapyObstetrics and GynecologyOdds ratiocase control studyMiddle AgedPatient Acceptance of Health CareHormone replacement therapyItalyTransgender hormone therapyHormone replacement therapy; case control study; menopauseFemalebusinessHuman
researchProduct

Sleep apnea and its role in transportation safety

2017

Obstructive sleep apnea (OSA) is a main cause of excessive daytime sleepiness and increases the risk for driving accidents, which can be normalized by treatment with continuous positive airway pressure ventilation. Since it is estimated that OSA is not diagnosed in about 80% of cases, recognition of patients at risk for driving accidents is a problem from both medical and societal points of view. Strategies to screen and identify subjects at high risk for driving accidents are under study in order to improve safety on the road, especially for commercial drivers, who show a high prevalence of OSA.

medicine.medical_specialtyObstructive Sleep Apneamedicine.medical_treatmentTransportation safetyExcessive daytime sleepinessReviewSettore MED/10 - Malattie Dell'Apparato RespiratorioGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicinelawCPAPAnesthesiologyDriving accidentmedicineContinuous positive airway pressureGeneral Pharmacology Toxicology and PharmaceuticsOpen peer reviewGeneral Immunology and Microbiologydriving accidentsSleep apneaArticlesGeneral MedicineSleep disordersmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemEmergency medicineVentilation (architecture)medicine.symptom030217 neurology & neurosurgery
researchProduct

Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study

2011

Published version of an article from the journal: BMC Research Notes. Also available from the publisher: http://dx.doi.org/10.1186/1756-0500-4-252 BACKGROUND:There is limited high-quality research investigating the efficacy of palliative radiation (PPR) with regard to symptoms and quality of life (QOL) among cancer patients with pelvic soft tissue tumors. As a result, clinicians are left with mainly retrospective studies, without reliable data on which to base treatment decisions. As a first step of a subsequent analysis of PPR's efficacy, we aimed to determine whether it is feasible to prospectively measure symptoms and QOL among patients treated with PPR. A secondary aim was to explore pa…

medicine.medical_specialtyPathologyAlternative medicinelcsh:MedicineGeneral Biochemistry Genetics and Molecular BiologyQuality of lifeMedicinelcsh:Science (General)Intensive care medicinelcsh:QH301-705.5Medicine(all)Bladder cancerBiochemistry Genetics and Molecular Biology(all)VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762business.industryRadiation Therapistlcsh:RCancerRetrospective cohort studyGeneral Medicinemedicine.diseasehumanitiesVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Radiology and diagnostic imaging: 763lcsh:Biology (General)Project NotePalliative radiationbusinessPelvic radiotherapylcsh:Q1-390BMC Research Notes
researchProduct

Flare in axial spondyloarthritis. The dark side of the outcome

2016

Spondyloarthritis (SpA) is a chronic inflammatory rheumatic disease with many phenotypes,1 but the frame of the disease is still a matter of debate, particularly regarding the non-radiographic forms of axial SpA.2 ,3 The disease evolution may have several profiles, mainly related to the treatment strategy, balancing from periods of remission or low disease activity to flares of the disease. The recommended treatment strategies are supposed to be tailored to the disease activity, aiming to reach remission or low disease activity in a T2T strategy,4 with management of remission (reduction of dosage or increase in interval of administration), as well as treatment intensification in case of fla…

medicine.medical_specialtyPathologyImmunologyDiseaseInflammatory bowel diseaseGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicineRheumatologylawSynovitisSpondylarthritismedicineHumansImmunology and AllergySpondylitis Ankylosing030212 general & internal medicineIntensive care medicine030203 arthritis & rheumatologyAnkylosing spondylitisbusiness.industryEnthesitismedicine.diseaseConnective tissue diseaseRheumatoid arthritismedicine.symptombusinessFlareAnnals of the Rheumatic Diseases
researchProduct